alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet
RxNorm concept 1368385, clinical drug (scd). Prescribable name: alogliptin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet.
- RxCUI
- 1368385
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368385 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / metFORMIN hydrochloride 1000 MG Oral Tablet; alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / metformin hydrochloride 1000 MG Oral Tablet; alogliptin 12.5 MG / metFORMIN hydrochloride 1000 MG Oral Tablet
Related concepts
- metformin hydrochloride 1000 MG (SCDC, consists of)
- alogliptin 12.5 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Kazano] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1368385 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368385 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1368385. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.